CARNIO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 982
EU - Europa 720
AS - Asia 531
SA - Sud America 20
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 2.271
Nazione #
US - Stati Uniti d'America 951
CN - Cina 214
IT - Italia 192
SE - Svezia 94
IE - Irlanda 81
TR - Turchia 74
GB - Regno Unito 62
FR - Francia 59
DE - Germania 46
SG - Singapore 41
HK - Hong Kong 33
JP - Giappone 33
AT - Austria 32
IN - India 32
VN - Vietnam 29
NL - Olanda 20
TW - Taiwan 19
CA - Canada 18
ES - Italia 18
KR - Corea 17
FI - Finlandia 14
PL - Polonia 14
JO - Giordania 12
AU - Australia 11
UA - Ucraina 11
MX - Messico 10
PE - Perù 9
BA - Bosnia-Erzegovina 8
BR - Brasile 8
HR - Croazia 8
RO - Romania 8
RU - Federazione Russa 8
BE - Belgio 7
IR - Iran 7
PK - Pakistan 7
GR - Grecia 6
CH - Svizzera 4
DK - Danimarca 4
RS - Serbia 4
SI - Slovenia 4
AP - ???statistics.table.value.countryCode.AP??? 3
EG - Egitto 3
GT - Guatemala 3
HU - Ungheria 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
AR - Argentina 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
ME - Montenegro 2
MT - Malta 2
AM - Armenia 1
CO - Colombia 1
EU - Europa 1
IL - Israele 1
PT - Portogallo 1
Totale 2.271
Città #
Chandler 96
Dublin 81
Beijing 70
Fairfield 63
Ashburn 62
Nyköping 43
Ann Arbor 37
Torino 35
Houston 33
Turin 33
Cambridge 31
Vienna 29
Wilmington 28
Woodbridge 27
Central 25
Singapore 24
Pisa 22
Milan 20
Princeton 20
Medford 17
Seattle 17
Villeurbanne 17
Nutley 16
Dearborn 14
Dong Ket 13
Hangzhou 13
Redwood City 13
Shanghai 13
Amman 12
Amsterdam 12
Chengdu 12
London 11
New York 11
Warsaw 11
Paris 10
Taipei 10
Mumbai 9
Rome 9
Seoul 8
Tokyo 8
Boston 7
Hebei 7
Norwalk 7
Banja Luka 6
Guangzhou 6
Karachi 6
Lima 6
Preveza 6
Zhengzhou 6
Boardman 5
Changchun 5
Chaponost 5
Madrid 5
Munich 5
New Delhi 5
Sydney 5
Tianjin 5
Xian 5
Zagreb 5
Ankara 4
Belgrade 4
Brookline 4
Castellaneta 4
Changsha 4
Falls Church 4
Guiyang 4
Jacksonville 4
Manchester 4
Nanjing 4
Newcastle upon Tyne 4
Preston 4
San Diego 4
San Francisco 4
Shinjuku 4
Toulouse 4
Utrecht 4
Bengaluru 3
Berlin 3
Bethesda 3
Chennai 3
Coyoacán 3
Cuauhtémoc 3
Florence 3
Fuzhou 3
Genay 3
Guatemala City 3
Hefei 3
Izmir 3
Jinan 3
Kaunas 3
Mandaluyong City 3
Ramallah 3
Shenyang 3
Silver Spring 3
Stockholm 3
Stratford 3
Vancouver 3
Washington 3
Wuhu 3
Yokozutsumi 3
Totale 1.282
Nome #
Extending survival of stage IV non-small cell lung cancer. 495
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer 309
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 257
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma 205
Fatigue in lung cancer patients: symptom burden and management of challenges. 131
Pulmonary Arterial Hypertension in ALK Receptor Tyrosine Kinase–Positive Lung Cancer Patient: Adverse Event or Disease Spread? 102
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey. 88
Osimertinib-induced Cardiac Dysfunction in EGFRMutated Lung Cancer: A Case Series of Five Patients 85
Prognostic and predictive biomarkers in early stage non-small cell lung cancer: Tumor based approaches including gene signatures 80
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey. 69
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave 68
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG 65
A challenge to overcome: the maintenance of the global quality of life in patients with advanced or metastatic non-small cell lung cancer 64
Pericarditis during chemoimmunotherapy for non–small cell lung cancer: an adverse event to prevent and recognise 57
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics 57
Black Hairy Tongue After Immune Checkpoint Inhibitors in NSCLC: A Case Report and Review of the Literature 53
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features 44
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer 36
Squamous cell histological transformation in a lung adenocarcinoma patient (hyper) progressing upon immunotherapy 32
How to personalize perioperative chemotherapy in early non-small cell lung cancer? 31
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling 9
Totale 2.337
Categoria #
all - tutte 6.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 19 15 14 26 7 23 24 15 13 23 11 6
2020/2021222 9 10 6 16 10 11 14 18 17 16 27 68
2021/2022371 31 8 15 30 27 12 20 22 7 29 128 42
2022/2023550 30 44 22 44 51 102 46 44 72 29 43 23
2023/2024420 57 79 35 38 19 49 22 27 5 35 29 25
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 2.337